Delaware for WuXi STA campus
Chinese CDMO WuXi STA is to build a new pharmaceutical clinical and commercial manufacturing complex on a 78-hectare campus in Middletown, Delaware. This has been supported by the Delaware Prosperity Partnership, other state departments and local government bodies, and received grants from the Delaware Strategic Fund.
The facility is WuXi STA’s second in the US and eighth world-wide. It will feature space for testing laboratories, API manufacture and the manufacture and packaging of solid dosage pharmaceutical products and sterile products. Due open in 2024, it should bring 500 full-time jobs by 2026, with the potential to grow to 1,000 in time.